106 results
8-K
EX-10.1
IKT
Inhibikase Therapeutics Inc
20 May 24
Inhibikase Therapeutics Announces Pricing of Registered Direct Offering and Warrant
8:55am
, immaterial, year-end audit adjustments.
(k) Material Changes; Undisclosed Events, Liabilities or Developments. Since the date of the latest audited
8-K
EX-99.1
xjnbu
30 Apr 24
Regulation FD Disclosure
8:17am